HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing into clinical practice new in vitro diagnostic technology for hemostasis - thrombodynamics.

Thrombodynamics assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis.

Value proposition: we help clinicians succeed, providing clear and reliable estimation of patients coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.